Critical Quality Metrics in Cell Sample Prep for Cell & Gene Therapy Bioanalytics
Now Watchinghttps://youtu.be/vEgp_FSQHF8 In this panel discussion, Virginia Litwin, Ph.D. (CRL), Christoph Eberle, MICR, FRSPH (CRL), Mahwish Natalia, MA, Ph.D. (Takeda Oncology), and Melvin Lye, MBA (Curiox Biosystems) discuss the role of partnerships between early- and late-stream analytical assay developers. While tackling unique challenges in validating flow cytometric methods for Chimeric Antigen Receptor (CAR) T cells, […]
Could Debris Be Masking Your True Results
Now Watchinghttps://www.youtube.com/watch?v=TlQaihGArto Sample preparation is the stage that can make or break an assay’s performance. Preserving the natural state of samples without having to sacrifice population size can be the difference between innovation and stagnation. Now more than ever, we need dependable, reproducible results that don’t require a lab magician. With Laminar Wash, we can […]
Manufacturing Living Therapies
Enabling “next-generation” drugs through automation and standardization This article was first published on Charles River Laboratories Eureka Blog. Please support our partners at Charles River. Cell and gene therapy continues to drive biopharmaceutical investment and pipelines, despite COVID-related research and clinical trial disruptions. Last year, the global cell therapy market size was $7.8 billion, expanding annually […]
Towards standardizing flow cytometry sample preparation protocols without centrifugation
Now Watchinghttps://youtu.be/NTTfiQiqhqE In this sponsored webinar by the flowcytometryUK society webinar, renowned flow cytometrist Derek Davies, Ph.D. of the Francis Crick Institute hosted a discussion featuring Curiox Applications Scientist Noma Ngwenya and Charles River Laboratories Principal Scientist III and Flow Cytometry Core Director Christoph Eberle, Ph.D. They explored how Laminar Wash™ technology enhances sample preparation for flow cytometry by […]
Curiox Laminar Wash Featured on Charles River Lab’s Eureka Science Blog
Collaboration with Charles River Laboratories expands Pharmaceutical and biotech companies, contract research organizations, and academics worldwide have discovered that Laminar Wash™ technology can improve their cellular analysis data quality and sample preparation workflows. Among Curiox’s customers is Charles River Laboratories (CRL), the world leader in addressing the challenges of pharmaceutical development. An early adopter of […]
How to wash away barriers to therapeutic cancer vaccine development
Developing neoantigen-based cancer vaccines necessitates comprehensive cellular characterization for iterative therapeutic improvement, which Laminar Wash™ systems may facilitate at multiple steps. Vaccines are probably the second-most effective advancement in the annals of human medicine, after sanitation. Most of us recognize the value of vaccines in infectious disease. Yet, swept under the rug amongst the COVID-19 global pandemic is another form of immune-boosting injection combating a terrible […]